痛打 发表于 2025-3-23 11:48:48

http://reply.papertrans.cn/3/223/22214/22214-11.png

pulmonary-edema 发表于 2025-3-23 17:35:43

Submitted on: 02 November 2021.
Revised on: 28 November 2021.
Accepted on: 23 December 2021.
MOLECULAR CANCER THERAPEUTICS

平项山 发表于 2025-3-23 20:50:55

http://reply.papertrans.cn/3/223/22214/22214-13.png

Dysarthria 发表于 2025-3-23 23:51:32

http://reply.papertrans.cn/3/223/22214/22214-14.png

Mawkish 发表于 2025-3-24 04:01:02

Submitted on: 22 September 2010.
Revised on: 03 October 2010.
Accepted on: 14 October 2010.
MOLECULAR CANCER THERAPEUTICS

值得赞赏 发表于 2025-3-24 07:32:05

Submitted on: 29 July 2006.
Revised on: 03 September 2006.
Accepted on: 13 September 2006.
MOLECULAR CANCER THERAPEUTICS---AMER ASSOC CANCER RESEARCH

Lacunar-Stroke 发表于 2025-3-24 12:53:46

Submitted on: 01 January 2012.
Revised on: 10 February 2012.
Accepted on: 02 March 2012.
MOLECULAR CANCER THERAPEUTICS

连词 发表于 2025-3-24 17:18:11

http://reply.papertrans.cn/3/223/22214/22214-18.png

BLAND 发表于 2025-3-24 21:34:08

http://reply.papertrans.cn/3/223/22214/22214-19.png

一骂死割除 发表于 2025-3-24 23:45:01

http://reply.papertrans.cn/3/223/22214/22214-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊MOLECULAR CANCER THERAPEUTICS 2024/2025影响因子:5.386 (MOL CANCER THER) (1535-7163). (ONCOLOGY)(肿瘤学)Science Citation